310 related articles for article (PubMed ID: 32603599)
1. Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell.
Guo M; Yu JJ; Perl AK; Wikenheiser-Brokamp KA; Riccetti M; Zhang EY; Sudha P; Adam M; Potter A; Kopras EJ; Giannikou K; Potter SS; Sherman S; Hammes SR; Kwiatkowski DJ; Whitsett JA; McCormack FX; Xu Y
Am J Respir Crit Care Med; 2020 Nov; 202(10):1373-1387. PubMed ID: 32603599
[No Abstract] [Full Text] [Related]
2. Mast-Cell Tryptase Release Contributes to Disease Progression in Lymphangioleiomyomatosis.
Babaei-Jadidi R; Dongre A; Miller S; Castellanos Uribe M; Stewart ID; Thompson ZM; Nateri AS; Bradding P; May ST; Clements D; Johnson SR
Am J Respir Crit Care Med; 2021 Aug; 204(4):431-444. PubMed ID: 33882264
[No Abstract] [Full Text] [Related]
3. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.
Carsillo T; Astrinidis A; Henske EP
Proc Natl Acad Sci U S A; 2000 May; 97(11):6085-90. PubMed ID: 10823953
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular insights into lymphangioleiomyomatosis.
Steagall WK; Taveira-DaSilva AM; Moss J
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
[TBL] [Abstract][Full Text] [Related]
5. Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model.
Prizant H; Taya M; Lerman I; Light A; Sen A; Mitra S; Foster TH; Hammes SR
Endocr Relat Cancer; 2016 Apr; 23(4):265-80. PubMed ID: 26880751
[TBL] [Abstract][Full Text] [Related]
6. Lymphangioleiomyomatosis (LAM) Cell Atlas.
Du Y; Guo M; Wu Y; Wagner A; Perl AK; Wikenheiser-Brokamp K; Yu J; Gupta N; Kopras E; Krymskaya V; Obraztsova K; Tang Y; Kwiatkowski D; Henske EP; McCormack F; Xu Y
Thorax; 2023 Jan; 78(1):85-87. PubMed ID: 36599466
[TBL] [Abstract][Full Text] [Related]
7. Connectivity Map Analysis of a Single-Cell RNA-Sequencing -Derived Transcriptional Signature of mTOR Signaling.
Al Mahi N; Zhang EY; Sherman S; Yu JJ; Medvedovic M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922083
[TBL] [Abstract][Full Text] [Related]
8. The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.
Steagall WK; Pacheco-Rodriguez G; Darling TN; Torre O; Harari S; Moss J
Am J Respir Cell Mol Biol; 2018 Jun; 58(6):678-683. PubMed ID: 29406787
[TBL] [Abstract][Full Text] [Related]
9. Lymphangioleiomyomatosis: A Monogenic Model of Malignancy.
Krymskaya VP; McCormack FX
Annu Rev Med; 2017 Jan; 68():69-83. PubMed ID: 28099079
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
[TBL] [Abstract][Full Text] [Related]
11. Lymphangioleiomyomatosis: a metastatic lung disease.
Kundu N; Holz MK
Am J Physiol Cell Physiol; 2023 Feb; 324(2):C320-C326. PubMed ID: 36571446
[TBL] [Abstract][Full Text] [Related]
12. Emerging biomarkers of lymphangioleiomyomatosis.
Nijmeh J; El-Chemaly S; Henske EP
Expert Rev Respir Med; 2018 Feb; 12(2):95-102. PubMed ID: 29171770
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue.
Espín R; Baiges A; Blommaert E; Herranz C; Roman A; Saez B; Ancochea J; Valenzuela C; Ussetti P; Laporta R; Rodríguez-Portal JA; van Moorsel CHM; van der Vis JJ; Quanjel MJR; Villar-Piqué A; Diaz-Lucena D; Llorens F; Casanova Á; Molina-Molina M; Plass M; Mateo F; Moss J; Pujana MA
Mol Cancer Res; 2021 Nov; 19(11):1840-1853. PubMed ID: 34312290
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Lymphangioleiomyomatosis originates in the pleural mesothelial cell population.
Clements D; Miller S; Johnson SR
Med Hypotheses; 2020 Aug; 141():109703. PubMed ID: 32276237
[TBL] [Abstract][Full Text] [Related]
16. Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis.
Ando K; Fujino N; Mitani K; Ota C; Okada Y; Kondo T; Mizobuchi T; Kurihara M; Suzuki K; Hoshika Y; Ebana H; Kobayashi E; Takahashi K; Kubo H; Seyama K
Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(10):L899-908. PubMed ID: 27016587
[TBL] [Abstract][Full Text] [Related]
17. Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing.
Fujita A; Ando K; Kobayashi E; Mitani K; Okudera K; Nakashima M; Miyatake S; Tsurusaki Y; Saitsu H; Seyama K; Miyake N; Matsumoto N
Hum Genet; 2016 Jan; 135(1):61-8. PubMed ID: 26563443
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis.
Grzegorek I; Lenze D; Chabowski M; Janczak D; Szolkowska M; Langfort R; Szuba A; Dziegiel P
Anticancer Res; 2015 Jun; 35(6):3353-60. PubMed ID: 26026095
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline.
Obraztsova K; Basil MC; Rue R; Sivakumar A; Lin SM; Mukhitov AR; Gritsiuta AI; Evans JF; Kopp M; Katzen J; Robichaud A; Atochina-Vasserman EN; Li S; Carl J; Babu A; Morley MP; Cantu E; Beers MF; Frank DB; Morrisey EE; Krymskaya VP
Nat Commun; 2020 Nov; 11(1):5640. PubMed ID: 33159078
[TBL] [Abstract][Full Text] [Related]
20. Giles F. Filley Lecture. Genetics and gene expression in lymphangioleiomyomatosis.
Pacheco-Rodriguez G; Kristof AS; Stevens LA; Zhang Y; Crooks D; Moss J
Chest; 2002 Mar; 121(3 Suppl):56S-60S. PubMed ID: 11893686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]